Azenta (AZTA) Set to Announce Earnings on Tuesday

Azenta (NASDAQ:AZTAGet Rating) is scheduled to issue its quarterly earnings data after the market closes on Tuesday, August 9th. Analysts expect the company to announce earnings of $0.10 per share for the quarter. Azenta has set its Q3 2022 guidance at $0.09-$0.17 EPS and its Q3 guidance at $0.09-0.17 EPS.Investors that are interested in participating in the company’s conference call can do so using this link.

Azenta (NASDAQ:AZTAGet Rating) last issued its quarterly earnings data on Monday, May 9th. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.01. Azenta had a net margin of 301.05% and a return on equity of 4.28%. The company had revenue of $145.60 million for the quarter, compared to analyst estimates of $142.10 million. During the same period in the prior year, the firm earned $0.61 earnings per share. The company’s revenue was up 12.3% on a year-over-year basis. On average, analysts expect Azenta to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Azenta Stock Performance

Shares of AZTA opened at $67.69 on Tuesday. The firm has a market cap of $5.08 billion, a P/E ratio of 2.29 and a beta of 1.48. Azenta has a 52 week low of $60.81 and a 52 week high of $124.79. The firm’s 50-day simple moving average is $71.28 and its 200 day simple moving average is $77.57.

Analysts Set New Price Targets

Several analysts recently weighed in on the company. Needham & Company LLC dropped their price target on Azenta from $115.00 to $94.00 in a report on Tuesday, May 10th. B. Riley lowered their price target on shares of Azenta from $94.00 to $82.00 in a research report on Thursday, July 14th.

Azenta Company Profile

(Get Rating)

Azenta, Inc provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows.

Featured Stories

Earnings History for Azenta (NASDAQ:AZTA)

Want More Great Investing Ideas?

Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with's FREE daily email newsletter.